Cointime

Download App
iOS & Android

Alnylam Pharmaceuticals

company
Exit Type
IPO
Exit Date
Jun 4, 2004

Exit parties in this round

Partner Fund Round Return Amount Return Multiplier
Merck Series Unknown Detail
Takeda Seed Detail
Regeneron Series B Detail
ARCH Venture Partners Series A Detail